Pfizer has announced the global withdrawal of its sickle cell disease treatment, Oxbryta (voxelotor), which was priced at approximately $125,000 per year.The post Pfizer withdraws $125,000 sickle cell treatment Oxbryta worldwide appeared first on Nairametrics.
Related Articles
Don't miss out on breaking stories and in-depth articles.